Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning.
暂无分享,去创建一个
Christos Davatzikos | Yong Fan | Jimit Doshi | Aristeidis Sotiras | Theodore D Satterthwaite | Nikolaos Koutsouleris | Eva Meisenzahl | Erdem Varol | Raymond Pomponio | Haochang Shou | Russell T Shinohara | Raquel E Gur | Ruben C Gur | Christos Pantelis | Benedicto Crespo-Facorro | Ganesh B Chand | Paola Dazzan | Hugo G Schnack | Guray Erus | Dhivya Srinivasan | Daniel H Wolf | Stephen J Wood | Chuanjun Zhuo | R. Kahn | R. Gur | R. Gur | C. Davatzikos | Yong Fan | D. Dwyer | N. Koutsouleris | C. Pantelis | H. Schnack | B. Crespo-Facorro | D. Wolf | G. Erus | J. Doshi | R. Shinohara | T. Satterthwaite | E. Meisenzahl | G. Busatto | S. Wood | M. Zanetti | A. Pigoni | P. Dazzan | C. Zhuo | E. Varol | G. Chand | H. Shou | Geraldo F Busatto | Marcus V Zanetti | Dominic B Dwyer | Alessandro Pigoni | Rene S Kahn | Raymond Pomponio | D. Srinivasan | Aristeidis Sotiras | S. Wood
[1] O. Howes,et al. Glutamate and dopamine in schizophrenia: An update for the 21st century , 2015, Journal of psychopharmacology.
[2] Christos Davatzikos,et al. Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms. , 2016, JAMA psychiatry.
[3] Christos Davatzikos,et al. Voxel-Based Morphometry Using the RAVENS Maps: Methods and Validation Using Simulated Longitudinal Atrophy , 2001, NeuroImage.
[4] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[5] D. Prvulovic,et al. Cortical–basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives , 2012, Schizophrenia Research.
[6] Antonio Vita,et al. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies , 2015, Biological Psychiatry.
[7] Christos Davatzikos,et al. Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods , 2019, Schizophrenia Research.
[8] Jiayu Chen,et al. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. , 2015, Schizophrenia bulletin.
[9] Isabelle Guyon,et al. A Stability Based Method for Discovering Structure in Clustered Data , 2001, Pacific Symposium on Biocomputing.
[10] B. Pollock,et al. Neuroimaging evidence for the deficit subtype of schizophrenia. , 2013, JAMA psychiatry.
[11] C. Zhuo,et al. Schizophrenia Patients Demonstrate Both Inter-Voxel Level and Intra-Voxel Level White Matter Alterations , 2016, PloS one.
[12] Tyrone D. Cannon. How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis , 2015, Trends in Cognitive Sciences.
[13] Brian Kirkpatrick,et al. The NIMH-MATRICS consensus statement on negative symptoms. , 2006, Schizophrenia bulletin.
[14] K. Kasai,et al. Abnormal asymmetries in subcortical brain volume in early adolescents with subclinical psychotic experiences , 2018, Translational Psychiatry.
[15] Deepti R. Bathula,et al. Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD , 2012, Proceedings of the National Academy of Sciences.
[16] R. Ophoff,et al. Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls. , 2012, Schizophrenia bulletin.
[17] Christos Davatzikos,et al. MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection , 2016, NeuroImage.
[18] Christos Davatzikos,et al. Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis. , 2015, Schizophrenia bulletin.
[19] L. Yao,et al. Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia. , 2015, The American journal of psychiatry.
[20] S. Lawrie,et al. Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: Preliminary findings from a 6-year follow-up study , 2016, British Journal of Psychiatry.
[21] T. Crow,et al. The two-syndrome concept: origins and current status. , 1985, Schizophrenia bulletin.
[22] Ronald Pierson,et al. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.
[23] P. Dazzan,et al. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings , 2009, Psychological Medicine.
[24] S. Lawrie,et al. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? , 2011, World psychiatry : official journal of the World Psychiatric Association.
[25] Jingyu Liu,et al. A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: application to schizophrenia, bipolar, and schizoaffective disorders , 2015, NeuroImage.
[26] Christian Gaser,et al. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology , 2010, NeuroImage.
[27] Christos Davatzikos,et al. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework , 2017, NeuroImage.
[28] Wolf Singer,et al. Oscillations and Neuronal Dynamics in Schizophrenia: The Search for Basic Symptoms and Translational Opportunities , 2015, Biological Psychiatry.
[29] R. Gur,et al. Multisite Machine Learning Analysis Provides a Robust Structural Imaging Signature of Schizophrenia Detectable Across Diverse Patient Populations and Within Individuals , 2018, Schizophrenia bulletin.
[30] Maximilian Reiser,et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study , 2008, NeuroImage.
[31] D. Wolf,et al. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. , 2014, Schizophrenia bulletin.
[32] S. Kapur,et al. The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.
[33] O. Howes,et al. Brain-imaging studies of treatment-resistant schizophrenia: a systematic review. , 2016, The lancet. Psychiatry.
[34] A. Abi-Dargham,et al. The search for imaging biomarkers in psychiatric disorders , 2016, Nature Medicine.
[35] O. Howes,et al. Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: A Meta-analysis , 2017, JAMA psychiatry.
[36] S. Galderisi,et al. Deficit schizophrenia: an update , 2008, World psychiatry : official journal of the World Psychiatric Association.
[37] I. Melle,et al. Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models , 2018, JAMA psychiatry.
[38] Joachim M. Buhmann,et al. Stability-Based Validation of Clustering Solutions , 2004, Neural Computation.
[39] A. Voineskos,et al. Neuroimaging Heterogeneity in Psychosis: Neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation , 2020, Biological Psychiatry.
[40] Lauren E. Ethridge,et al. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. , 2016, The American journal of psychiatry.
[41] J. Turner,et al. Abnormal asymmetries in subcortical brain volume in schizophrenia , 2016, Molecular Psychiatry.
[42] Marek Kubicki,et al. Structural neuroimaging in schizophrenia from methods to insights to treatments , 2010, Dialogues in clinical neuroscience.
[43] Vincent Frouin,et al. Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents , 2019, JAMA psychiatry.
[44] Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis , 2014, Psychological Medicine.
[45] M. Ron,et al. A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis , 2014, Psychological Medicine.
[46] O. Howes,et al. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization , 2017, Translational Psychiatry.
[47] A. Meyer-Lindenberg,et al. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. , 2013, Schizophrenia bulletin.
[48] H. Sauer,et al. Patterns of cortical thinning in different subgroups of schizophrenia. , 2015, The British journal of psychiatry : the journal of mental science.
[49] V. Calhoun,et al. Brain Subtyping Enhances The Neuroanatomical Discrimination of Schizophrenia , 2018, Schizophrenia bulletin.
[50] J. Os,et al. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis , 2011, Neuroscience & Biobehavioral Reviews.
[51] L. Hubert,et al. Comparing partitions , 1985 .
[52] Cathryn F. Glanton,et al. Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder , 2013, Schizophrenia Research.
[53] R. Gur,et al. Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia. , 2010, The American journal of psychiatry.
[54] Chunshui Yu,et al. Neural substrates underlying delusions in schizophrenia , 2016, Scientific Reports.
[55] Igor Zwir,et al. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. , 2015, The American journal of psychiatry.
[56] Andrew Simmons,et al. Cortical folding defects as markers of poor treatment response in first-episode psychosis. , 2013, JAMA psychiatry.
[57] R. Kahn,et al. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. , 2013, Schizophrenia bulletin.
[58] B. Kirkpatrick,et al. The heterogeneity of the long-term course of schizophrenia. , 1988, Schizophrenia bulletin.
[59] Tyrone D. Cannon,et al. Prenatal inflammation and risk for schizophrenia: A role for immune proteins in neurodevelopment , 2018, Development and Psychopathology.
[60] Christos Davatzikos,et al. MIDAS: Regionally linear multivariate discriminative statistical mapping , 2018, NeuroImage.
[61] I. Melle,et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium , 2016, Molecular Psychiatry.
[62] S. Lui,et al. A transdiagnostic neuroanatomical signature of psychiatric illness , 2018, Neuropsychopharmacology.
[63] J. Trojanowski,et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers , 2016, Brain : a journal of neurology.
[64] Paola Dazzan,et al. Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude? , 2014, Dialogues in clinical neuroscience.
[65] A. Todt,et al. [Brain disorders]. , 1971, SA nursing journal. SA verplegingstydskrif.
[66] Sylvain Arlot,et al. A survey of cross-validation procedures for model selection , 2009, 0907.4728.